5th Pharmacovigilance & Drug Safety Summit
30-31

October 2019

Germany

Berlin

Hotel Eurostars Berlin

Friedrichstraße 99, 10117

About

With the goal of making medicine safe for people all over the world, there are few issues more important than drug safety. And while predicting the future is still impossible, technological developments continue to make it possible to be vigilant across the globe in this industry. To discuss this and more, we are pleased to invite you to the 5th Pharmacovigilance & Drug Safety Summit on Oct. 30-31, 2019, in Berlin, Germany. The two-day event will bring together top professionals working on the latest trends to be both proactive and predictive...

With the goal of making medicine safe for people all over the world, there are few issues more important than drug safety. And while predicting the future is still impossible, technological developments continue to make it possible to be vigilant across the globe in this industry. To discuss this and more, we are pleased to invite you to the 5th Pharmacovigilance & Drug Safety Summit on Oct. 30-31, 2019, in Berlin, Germany. The two-day event will bring together top professionals working on the latest trends to be both proactive and predictive in PV and drug safety in Europe as well as developing countries. Technologies like AI and automation will continue to transform what’s possible in the industry, and even social media has the potential to be a transformational tool in PV. Furthermore, attendees will hear real-world examples of advanced data management systems, real-time drug safety analysis and developing an effective PV audit strategy with a business partner. Don’t miss this opportunity to learn from experts and to network with managers, vice presidents, directors and C-Suite executives who work in PV and drug safety. We look forward to welcoming you in Berlin this October!

more info
Who Should Attend

CEOs/Presidents, Professors, Researchers, Chief Executives, Directors, Vice Presidents, PhD Students, Heads, Leaders and Managers specialising in:

  • QPPV
  • Risk Management
  • Pharmacoepidemiology
  • Signal Detection
  • Pharmacovigilance
  • Risk Assessment
  • Market Research Programs
  • PV Governance
  • Phase IV/Postmarketing Safety
  • Drug Safety
  • Patient Safety
  • Medical Affairs
  • Quality Assurance
  • Regulatory Affairs
  • Audit Readiness
  • Medical Safety
  • Safety Surveillance
Key Practical Learning Points of the Summit

Development and deployment of advanced data management systems
Proactive vs. predictive technologies in the future of PV
Real-time drug safety data analysis in medical monitoring
Does AI have a real role to play in PV?
Best practices for developing an overall PV audit strategy with a business partner
How has inspection preparation changed and what are the new methods on the horizon?
The role of surveys in controlling the overall risk management system
Is there a way to effectively and reliably use social media towards a QPPV’s end goals?
Speakers
Dr. Sutirtha Mukhopadhyay, BE

Global Safety Officer

Sanofi

Julia Appelskog, SE

Head of PV Strategy Office, Global Patient Safety

Merck

James Whitehead, UK

Principal in Pharmacovigilance Processes & Partnerships

AstraZeneca

Doris I. Stenver, DK

Founder/Independent PV Advisor

Unique Advice

Deji Alli, UK

Head of Pharmacovigilance

Healthcare at Home

Dr. Monika Manske, DE

Associate Director, Global Pharmacovigilance Governance Head, Pharmacovigilance Quality System

Mylan

Ricarda Tiemeyer, DE

Head of Drug Safety, Germany

Biogen

Klaudija Marijanovic Barac, HR

Senior Director, Teva Periodic Reports & Risk Management Centre

Teva Pharmaceuticals

Gabrielle Amselem, FR

Deputy EUQPPV

Alexion Pharmaceuticals

Jackie Roberts, UK

Executive Director of Regulatory, Pharmacovigilance & Medical UK/IE/Malta/MENA

Accord Healthcare

Giovanni Furlan, IT

Director, Safety Risk Leadd

Pfizer

Annual

Events

Previous Year Attendees
  • uniQure biopharma B.V. The Netherlands

    Pharmacovigilance Drug Safety Expert

  • Biotest AG Germany

    Corporate Drug Safety - Operations

  • PharmaLex GmbH Germany

    Global Head Pharmacovigilance

  • Läkemedelsverket Medical Products Agency Sweden

    Pharmacovigilance Inspector

  • Berlin-Chemie AG Germany

    Medical Assessor, Quality Assurance Manager

  • Zwiers Regulatory Consultancy B.V. The Netherlands

    QPPV

  • PharmaLex GmbH Germany

    Manager Pharmacovigilance

  • KRKA Slovenia

    Senior QA Associate

  • Sanofi Aventis Groupe France

    ITS Project Leader

  • PrimeVigilance Limited UK

    Director Global Pharmacovigilance Operations

  • G. Pohl-Boskamp GmbH & Co. KG Germany

    Director Pharmacovigilance

  • CureVac AG Germany

    Associate Medical Director

  • VISUfarma S.p.A. Italy

    Deputy QPPV and Regulatory Affairs Specialist

  • DBV Technologies France

    Drug Safety Pharmacist



more info
Sponsors and Partners

Sponsor

Sponsor

Media partner

Media partner

Media partner

Media partner

Media partner

"